{
    "title": "AstraZeneca touts independence as Nexium drug keeps on giving",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2823115/AstraZeneca-lifts-sales-forecast-Nexium-keeps-giving.html",
    "date": "2014-11-06",
    "keywords": [
        "tax",
        "astrazeneca",
        "drug",
        "pfizer",
        "nexium",
        "company",
        "percent",
        "quarter",
        "analyst",
        "bid",
        "year",
        "pipeline",
        "share",
        "gmt",
        "takeover",
        "thursday",
        "soriot",
        "investment",
        "inversion",
        "collapse",
        "shire",
        "focus",
        "bank",
        "core",
        "hit",
        "market",
        "cancer",
        "investor",
        "day",
        "independence",
        "november",
        "email",
        "ben",
        "hirschlerlondon",
        "standalone",
        "strength",
        "case",
        "drugmaker",
        "forecast",
        "row",
        "launch",
        "cash",
        "heartburn",
        "drugit",
        "exchange",
        "revenue",
        "factorchief",
        "executive",
        "kind",
        "megamerger",
        "outlook",
        "companys",
        "drugssoriot",
        "government",
        "rationale",
        "bar",
        "inverting",
        "acquisition",
        "deal",
        "run",
        "read",
        "week",
        "offer",
        "likelihood",
        "decision",
        "management",
        "buyback",
        "programme",
        "patel",
        "healthcare",
        "sector",
        "percentfloor",
        "earningssoriot",
        "end",
        "range",
        "control",
        "damage",
        "payment",
        "aegerion",
        "myalept",
        "move",
        "disease",
        "areasastrazeneca",
        "currency",
        "percentdeutsche",
        "mark",
        "clark",
        "amount",
        "relevance",
        "term",
        "return",
        "growth",
        "momentum",
        "raft",
        "patent",
        "loss",
        "exclusivity",
        "astrazenecas",
        "crestor",
        "competition"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}